Liverpool biocampus mulls LABV
10 April 2012
The Royal Liverpool and Broadgreen University Hospitals Trust (RLBUHT) is considering using a local asset-backed vehicle (LABV) approach to build a new £28m life science and innovation centre.
On behalf of the University of Liverpool and Liverpool City Council, the Trust is seeking to market test private contractors to see how Liverpool's new Bio Innovation Centre - the the first phase of the delivery of an international life science bio-campus - could be financed and built. The authority is looking for feedback on whether to procure the building using Procure 21+, a restricted negotiated procedure or a local asset-backed vehicle company.
The deal will involve the construction of a new innovation centre "to connect academics, industry professionals, investors, clinicians and the NHS", according to a statement. The centre will be built on a 10 hectare site in the ownership of RLBUHT, with full planning permission for commercial and research development.
The institutions' key objective is for the new campus to place Liverpool alongside Boston and Singapore as a leading international centre for the life sciences. Procurement works are hoped to begin by the end of 2012 with the centre being in full operation by May 2014.
